Corporate Research Fronts> Biological Sciences
October 2010
This list of corporate research fronts from Essential Science IndicatorsSM from Clarivate is from the from the second bimonthly period of 2010, and covers areas in the biological sciences. Source dates are May 30, 2004-April 30, 2010 (sliding 6-year period).
Research Front Name | % of corp. affiliations | Leading corp. |
---|---|---|
EARLY DRUG DISCOVERY USING HIGH-RESOLUTION LIQUID CHROMATOGRAPHY/QUADRUPOLE TIME-OF-FLIGHT MASS SPECTROMETRY | 62 | Waters Corp |
FULLY HUMAN TRAIL-RECEPTOR 1 MONOCLONAL ANTIBODY; RECOMBINANT HUMAN APOPTOSIS LIGAND 2/TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND (RHAPO2L/TRAIL) | 37 | Genentech, Inc |
PHARMACEUTICAL COCRYSTALS; HYDROGEN-BONDED MOLECULAR COCRYSTALS; SOLUTION COMPOSITION GENERATE PHARMACEUTICALLY ACCEPTABLE COCRYSTALS | 30 | TransForm Pharmaceuticals, Inc |
TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED PATIENT TREATMENT EFFICACY-SAFETY; TYPE 2 DIABETES FAILING THIAZOLIDINEDIONE MONOTHERAPY | 27 | Merck & Co, Inc |
DELTA-LIKE 4 NOTCH LIGAND; TUMOR ANGIOGENESIS; BLOCKING NEUROPILIN-2 FUNCTION INHIBITS TUMOR CELL METASTASIS | 26 | Regeneron Pharmaceuticals, Inc |
EVALUATING VIRTUAL SCREENING METHODS; VIRTUAL SCREENING USING MULTIPLE BIOACTIVE REFERENCE STRUCTURES; SIMILARITY-BASED VIRTUAL SCREENING USING 2D FINGERPRINTS | 25 | GlaxoSmithKline |
ENDOGENOUS HUMAN GENE CORRECTION ZINC-FINGER NUCLEASES; ZEBRAFISH USING ENGINEERED ZINC-FINGER NUCLEASES; GENOME EDITING USING ZINC-FINGER NUCLEASES | 24 | Sangamo BioSciences, Inc |
POLYETHYLENIMINE (PEI)-COMPLEXED SIRNA IN-VIVO; NONINFLAMMATORY SYNTHETIC SIRNA MEDIATING POTENT GENE SILENCING IN-VIVO | 22 | Alnylam Pharmaceuticals, Inc |
PROTON PUMP INHIBITORS FOLLOWING ACUTE CORONARY SYNDROME; STENT THROMBOSIS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION | 21 | Eli Lilly & Co |
2004-2010_2 |
Corporate Research Fronts
Research Fronts
About
Featured Image:
The eye of a goose is pictured at the Schwarzbauer geese farm in Hohenried near
Ingolstadt December 18, 2009.
REUTERS/Michaela Rehle.